IMI on the Move to Improve Drug Development in Europe
DUBLIN, Ireland – It has not been long since the first research programs got under way, but there is evidence already that projects undertaken by the €2 billion (US$2.4 billion) Innovative Medicines Initiative (IMI) are having an impact on the environment for drug development in Europe.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST